This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogène
This STARD13 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 544-573 amino acids from the Central region of human STARD13.
STARD13
Reactivité: Humain
ELISA, WB
Hôte: Lapin
Polyclonal
FITC
Indications d'application
For WB starting dilution is: 1:1000
Restrictions
For Research Use only
Format
Liquid
Concentration
0.32 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
4 °C,-20 °C
Stockage commentaire
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Antigène
STARD13
(StAR-Related Lipid Transfer (START) Domain Containing 13 (STARD13))
anticorps ARHGAP37, anticorps DLC2, anticorps GT650, anticorps LINC00464, anticorps RGD1564816, anticorps StAR related lipid transfer domain containing 13, anticorps StAR-related lipid transfer (START) domain containing 13, anticorps StAR-related lipid transfer domain containing 13, anticorps STARD13, anticorps Stard13
Sujet
This gene encodes a protein that contains a sterile alpha motif domain in the N-terminus, an ATP/GTP-binding motif, a GTPase-activating protein domain, and a STAR-related lipid transfer domain in the C-terminus. The gene is located in a region of chromosome 13 that has loss of heterozygosity in hepatic cancer. At least three alternatively spliced transcript variants have been described for this gene.